Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lannett Co. Inc (LCI)

Lannett Co. Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lannett Co. Inc 9000 STATE ROAD PHILADELPHIA PA 19136 USA

P: 215-333-9000

Description:

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate themselves into certain specialty markets and achieve economies in production are all critical for their success in the generic pharmaceutical industry in which they operate. Lannett Company, Inc., continues to dedicate significant capital toward developing new products as they believe their success is linked to their ability to continually introduce new generic products into the marketplace.

Key Statistics

Overview:

Market Capitalization, $K 353,957
Shares Outstanding, K 40,406
Annual Sales, $ 655,410 K
Annual Net Income, $ -272,110 K
Last Quarter Sales, $ 127,340 K
Last Quarter Net Income, $ -12,160 K
60-Month Beta 2.22
% of Insider Shareholders 12.57%
% of Institutional Shareholders 97.57%
Float, K 35,327
% Float 87.43%

Growth:

1-Year Return 62.68%
3-Year Return -59.63%
5-Year Return -80.76%
5-Year Revenue Growth 139.40%
5-Year Earnings Growth 18.69%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.22 on 11/06/19
Next Earnings Date N/A
Earnings Per Share ttm 2.13
EPS Growth vs. Prev Qtr -40.54%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 3-2 on 03/03/03

LCI Ratios

Ratio
Price/Earnings ttm 4.19
Price/Earnings forward 2.43
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 25.40
Return-on-Assets (Before Tax) 6.82
Profit Margin % -41.52
Net Margin % 3.83
Debt/Equity 1.98
Price/Sales 0.55
Price/Cash Flow 2.38
Price/Book 1.28
Book Value/Share 7.87
Interest Coverage -3.09
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar